Jingnan Shen Selected Research

Jingnan Shen Research Topics

Disease

30	Osteosarcoma (Osteogenic Sarcoma) 03/2022 - 03/2011
26	Neoplasms (Cancer) 09/2022 - 05/2009
10	Neoplasm Metastasis (Metastasis) 01/2022 - 02/2012
5	Sarcoma (Soft Tissue Sarcoma) 01/2021 - 07/2011
4	Pain (Aches) 03/2021 - 07/2010
3	Infections 01/2021 - 12/2011
2	Spontaneous Fractures (Pathological Fracture) 02/2019 - 09/2018
1	Mesenchymal Chondrosarcoma 01/2022
1	Pleural Effusion (Pleural Effusions) 01/2022
1	Margins of Excision 10/2020
1	Ewing Sarcoma (Sarcoma, Ewing) 10/2020
1	Alopecia (Baldness) 09/2018
1	Nausea 09/2018
1	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 09/2018
1	Surgical Wound Infection 09/2018
1	Retinoblastoma (Glioblastoma, Retinal) 01/2018
1	Hypertrophy 12/2012
1	Chondrosarcoma 04/2012
1	Testicular Neoplasms (Testicular Cancer) 04/2012
1	Melanoma (Melanoma, Malignant) 04/2012
1	Prosthesis Failure 12/2011
1	Mitochondrial Diseases (Mitochondrial Disease) 09/2011
1	Multiple Myeloma 03/2011
1	Lymphoma (Lymphomas) 03/2011

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 12/2021 - 02/2012
5	Biomarkers (Surrogate Marker)IBA 03/2022 - 04/2012
4	Pharmaceutical PreparationsIBA 01/2022 - 09/2014
3	Alkaline PhosphataseIBA 01/2022 - 02/2012
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020 - 06/2013
3	Methotrexate (Mexate)FDA LinkGeneric 01/2018 - 09/2011
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 05/2015
2	Biological ProductsIBA 08/2021 - 12/2012
2	Long Noncoding RNAIBA 01/2020 - 10/2017
2	Messenger RNA (mRNA)IBA 01/2020 - 01/2014
2	QuercetinIBA 03/2012 - 09/2011
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Leucovorin (Folinic Acid)FDA Link 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 12/2021
1	Bone Cements (Bone Glue)IBA 01/2021
1	Adenosine Triphosphatases (ATPase)IBA 01/2021
1	PlasticsIBA 09/2020
1	CB-5083IBA 01/2020
1	niraparibIBA 01/2020
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020
1	Tumor Biomarkers (Tumor Markers)IBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	SecurinIBA 11/2019
1	Cyclin A2IBA 11/2019
1	Cyclin B2IBA 11/2019
1	Denosumab FDA Link 02/2019
1	Transaminases (Aminotransferases)IBA 09/2018
1	E2F Transcription FactorsIBA 01/2018
1	Therapeutic UsesIBA 01/2018
1	Hemoglobins (Hemoglobin)IBA 01/2018
1	degalactotigoninIBA 01/2018
1	CateninsIBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	dioscinIBA 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	Competitive Endogenous RNAIBA 01/2017
1	Circular RNAIBA 01/2017
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 08/2015
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 08/2015
1	Tyrosine Kinase InhibitorsIBA 08/2015
1	Celecoxib (Celebrex)FDA Link 08/2015
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 08/2015
1	vandetanib (ZD6474)IBA 08/2015
1	Circulating Tumor DNAIBA 05/2015
1	AMP-Activated Protein KinasesIBA 09/2014
1	p38 Mitogen-Activated Protein KinasesIBA 09/2014
1	dihydromyricetinIBA 09/2014
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2014
1	Protein Isoforms (Isoforms)IBA 01/2014
1	Protons (Proton)IBA 01/2014
1	LigandsIBA 06/2013
1	ChemokinesIBA 06/2013
1	ImmunosorbentsIBA 06/2013
1	EnzymesIBA 06/2013
1	OligonucleotidesIBA 04/2012
1	AntigensIBA 04/2012
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 02/2012
1	Monoclonal AntibodiesIBA 03/2011
1	Complement System Proteins (Complement)IBA 03/2011
1	Rituximab (Mabthera)FDA Link 03/2011

Therapy/Procedure

8	Drug Therapy (Chemotherapy) 10/2020 - 05/2009
7	Prostheses and Implants (Prosthesis) 09/2022 - 07/2010
4	Limb Salvage 09/2022 - 12/2011
3	Operative Surgical Procedures 09/2022 - 02/2019
3	Surgical Amputation (Amputations) 01/2021 - 11/2018
3	Therapeutics 10/2020 - 03/2011
2	Curettage 03/2021 - 02/2019
2	Immunotherapy 04/2012 - 03/2011
1	Metastasectomy 01/2022
1	Length of Stay 03/2021
1	Arthroplasty 01/2021
1	Bone Transplantation (Bone Grafting) 09/2018
1	Adjuvant Chemotherapy 01/2018
1	Oral Administration 01/2018
1	X-Ray Film 12/2011
1	Arthrodesis 07/2011